January 10: As Congress Returns, Lawmakers Rush to Detail Drug-Pricing Agendas

Chuck Grassley wasted little time this week in unveiling his drug-pricing agenda, attaching his name to a trio of bills that, as the new chair of the Senate Finance Committee, he is freshly empowered to advance.

Grassley, an Iowa Republican, was among the many lawmakers who hurried to announce bills to lower drug costs, many of which have stalled in past sessions but that now enjoy renewed enthusiasm, as President Trump and Democrats on Capitol Hill continue their pharmaceutical industry focus.

Read the full article here on STAT.